- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Aug 2, 2019
Product Development
Boehringer plays catch-up in NASH, dives into new modalities across the board
Keeping to early stage deals, Boehringer places smaller bets on big risks
BioCentury | Nov 1, 2018
Finance
OrbiMed’s NASH Terns
Why OrbiMed led $80 million B round for U.S.-China NASH company Terns
Items per page:
1 - 10 of 12